SCHEMBL19320365

SCHEMBL19320365

Cc1ccc(S(=O)(=O)n2cc(B3OC(C)(C)C(C)(C)O3)c3c(C)ncnc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ POLB P06746 1/20 0.35
▸ ALDH3A1 P30838 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ ELANE P08246 1/20 0.34
▸ PRTN3 P24158 1/20 0.34
▸ PKM P14618 1/20 0.33
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ UBE2N P61088 1/20 0.32
▸ P2RX4 Q99571 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PTPN11 Q06124 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29605515 0.84 L3MBTL1 (0.41) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL29605609 0.83 L3MBTL1 (0.35) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL20576354 0.82 L3MBTL1 (0.34) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL5136088 0.81 L3MBTL1 (0.36) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL19320368 0.80 L3MBTL1 (0.39) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL15401147 0.80 NPC1 (0.40) KDM4EMAPTKMT2AMEN1
SCHEMBL29604745 0.80 L3MBTL1 (0.43) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL29605448 0.79 L3MBTL1 (0.37) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL10006748 0.79 PIM1 (0.33) L3MBTL1POLBALDH3A1HTTNOD1
SCHEMBL3502348 0.78 PTPN11 (0.40) L3MBTL1POLBALDH3A1HTTNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9932346-B2 Pyrrolopyrimidines for use in influenza virus infection JANSSEN SCIENCES IRELAND UC (IE) 2018-04-03 — — US disclosed
US-20170253600-A1 PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION JANSSEN INFECTIOUS DISEASES BVBA (BE) 2017-09-07 — — US disclosed
US-20170253600-A1 PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION JANSSEN INFECTIOUS DISEASES BVBA (BE) 2017-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253600-A1 PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION IMPDH1, IMPDH2, TYMP L3MBTL1 4003/4885POLB 133/4885ALDH3A1 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback